Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

131 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice.
Kajikawa S, Harada T, Kawashima A, Imada K, Mizuguchi K. Kajikawa S, et al. Prostaglandins Leukot Essent Fatty Acids. 2009 Apr;80(4):229-38. doi: 10.1016/j.plefa.2009.02.004. Epub 2009 Mar 27. Prostaglandins Leukot Essent Fatty Acids. 2009. PMID: 19328666
Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet.
Kajikawa S, Imada K, Takeuchi T, Shimizu Y, Kawashima A, Harada T, Mizuguchi K. Kajikawa S, et al. Dig Dis Sci. 2011 Apr;56(4):1065-74. doi: 10.1007/s10620-010-1400-5. Epub 2010 Sep 17. Dig Dis Sci. 2011. PMID: 20848203
Suppression of hepatic fat accumulation by highly purified eicosapentaenoic acid prevents the progression of d-galactosamine-induced hepatitis in mice fed with a high-fat/high-sucrose diet.
Kajikawa S, Harada T, Kawashima A, Imada K, Mizuguchi K. Kajikawa S, et al. Biochim Biophys Acta. 2009 Apr;1791(4):281-8. doi: 10.1016/j.bbalip.2009.01.014. Epub 2009 Jan 31. Biochim Biophys Acta. 2009. PMID: 19416647
Impaired fertility in female mice lacking urinary trypsin inhibitor.
Sato H, Kajikawa S, Kuroda S, Horisawa Y, Nakamura N, Kaga N, Kakinuma C, Kato K, Morishita H, Niwa H, Miyazaki J. Sato H, et al. Biochem Biophys Res Commun. 2001 Mar;281(5):1154-60. doi: 10.1006/bbrc.2001.4475. Biochem Biophys Res Commun. 2001. PMID: 11243855
Lipoteichoic acid induces preterm delivery in mice.
Kajikawa S, Kaga N, Futamura Y, Kakinuma C, Shibutani Y. Kajikawa S, et al. J Pharmacol Toxicol Methods. 1998 Apr;39(3):147-54. doi: 10.1016/s1056-8719(98)00015-x. J Pharmacol Toxicol Methods. 1998. PMID: 9741389
Protection against preterm delivery in mice by urinary trypsin inhibitor.
Futamura Y, Kajikawa S, Kaga N, Shibutani Y. Futamura Y, et al. Obstet Gynecol. 1999 Jan;93(1):100-8. doi: 10.1016/s0029-7844(98)00396-2. Obstet Gynecol. 1999. PMID: 9916965
Tocolytic effect of magnesium sulfate and/or urinary trypsin inhibitor against lipopolysaccharide-induced preterm delivery in mice.
Kajikawa S, Kaga N, Futamura Y, Shibutani Y. Kajikawa S, et al. Acta Obstet Gynecol Scand. 1998 Jul;77(6):598-602. doi: 10.1034/j.1600-0412.1998.770604.x. Acta Obstet Gynecol Scand. 1998. PMID: 9688235
Magnesium (4, 5, 6, 7, or 8 mg/hr, s.c.), UTI (25 x 10(4) units/kg, i.p.), magnesium (5 mg/hr, s.c.) plus UTI (25 x 10(4) units/kg, i.p.), saline solution (0.3 ml/hr, s.c.), or saline solution (0.1 ml/hr, s.c. and 2.5 ml/kg, i.p.) was administered to p …
Magnesium (4, 5, 6, 7, or 8 mg/hr, s.c.), UTI (25 x 10(4) units/kg, i.p.), magnesium (5 mg/hr, s.c.) plus UTI (25 x 10(4) unit …
131 results
Jump to page
Feedback